BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 26650437)

  • 21. Higher initial tacrolimus blood levels and concentration-dose ratios in kidney transplant recipients who develop diabetes mellitus.
    Rodrigo E; de Cos MA; Fernández-Fresnedo G; Sánchez B; Ruiz JC; Piñera C; Palomar R; Cotorruelo JG; Gómez-Alamillo C; de Castro SS; de Francisco AL; Arias M
    Transplant Proc; 2005 Nov; 37(9):3819-20. PubMed ID: 16386549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International consensus on post-transplantation diabetes mellitus.
    Sharif A; Chakkera H; de Vries APJ; Eller K; Guthoff M; Haller MC; Hornum M; Nordheim E; Kautzky-Willer A; Krebs M; Kukla A; Kurnikowski A; Schwaiger E; Montero N; Pascual J; Jenssen TG; Porrini E; Hecking M
    Nephrol Dial Transplant; 2024 Feb; 39(3):531-549. PubMed ID: 38171510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance in kidney allograft recipients treated with calcineurin inhibitors.
    Wyzgał J; Paczek L; Sańko-Resmer J; Ciszek M; Nowak M; Rowiński W; Szmidt J; Durlik M
    Ann Transplant; 2007; 12(2):26-9. PubMed ID: 18173063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Posttransplantation Diabetes Mellitus Among Solid Organ Recipients in a Danish Cohort.
    Dos Santos Q; Hornum M; Terrones-Campos C; Crone CG; Wareham NE; Soeborg A; Rasmussen A; Gustafsson F; Perch M; Soerensen SS; Lundgren J; Feldt-Rasmussen B; Reekie J
    Transpl Int; 2022; 35():10352. PubMed ID: 35449717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-transplant diabetes mellitus.
    Salvadori M; Bertoni E; Rosati A; Zanazzi M
    J Nephrol; 2003; 16(5):626-34. PubMed ID: 14733407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal posttransplantation diabetes mellitus: An overview.
    Pimentel AL; Bauer AC; Camargo JL
    Clin Chim Acta; 2015 Oct; 450():327-32. PubMed ID: 26368267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-transplant diabetes mellitus: the last 10 years with tacrolimus.
    Bäckman LA
    Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi13-vi16. PubMed ID: 15575021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: A systematic review and meta-analysis.
    Oliveras L; Coloma A; Lloberas N; Lino L; Favà A; Manonelles A; Codina S; Couceiro C; Melilli E; Sharif A; Hecking M; Guthoff M; Cruzado JM; Pascual J; Montero N
    Transplant Rev (Orlando); 2024 Jul; 38(3):100856. PubMed ID: 38723582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing survival outcomes for kidney transplant recipients with pre-existing diabetes versus those who develop post-transplantation diabetes.
    Hussain A; Culliford A; Phagura N; Evison F; Gallier S; Sharif A
    Diabet Med; 2022 Feb; 39(2):e14707. PubMed ID: 34599527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of pre-transplant dialysis modality on post-transplant diabetes mellitus after kidney transplantation.
    Courivaud C; Ladrière M; Toupance O; Caillard S; Hurault de Ligny B; Ryckelynck JP; Moulin B; Rieu P; Frimat L; Chalopin JM; Chauvé S; Kazory A; Ducloux D
    Clin Transplant; 2011; 25(5):794-9. PubMed ID: 21158919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging treatments for post-transplantation diabetes mellitus.
    Jenssen T; Hartmann A
    Nat Rev Nephrol; 2015 Aug; 11(8):465-77. PubMed ID: 25917553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges in the diagnosis and management of new-onset diabetes after transplantation.
    Salifu MO; Tedla F; Murty PV; Aytug S; McFarlane SI
    Curr Diab Rep; 2005 Jun; 5(3):194-9. PubMed ID: 15929866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppressive drug-induced diabetes.
    Penfornis A; Kury-Paulin S
    Diabetes Metab; 2006 Dec; 32(5 Pt 2):539-46. PubMed ID: 17130815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posttransplant diabetes mellitus: Impact of good blood glucose regulation on renal transplant recipient outcome.
    Sezer S; Akgul A; Altunoglu A; Arat Z; Ozdemir FN; Haberal M
    Transplant Proc; 2006 Mar; 38(2):533-6. PubMed ID: 16549167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. pre-existing diabetes and PTDM in kidney transplant recipients: how to handle immunosuppression.
    Chevallier E; Jouve T; Rostaing L; Malvezzi P; Noble J
    Expert Rev Clin Pharmacol; 2021 Jan; 14(1):55-66. PubMed ID: 33196346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-transplant diabetes mellitus in lung transplant recipients: incidence and risk factors.
    Ollech JE; Kramer MR; Peled N; Ollech A; Amital A; Medalion B; Saute M; Shitrit D
    Eur J Cardiothorac Surg; 2008 May; 33(5):844-8. PubMed ID: 18339554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutritional and metabolic issues in solid organ transplantation: targets for future research.
    Ward HJ
    J Ren Nutr; 2009 Jan; 19(1):111-22. PubMed ID: 19121784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New-onset diabetes after transplantation.
    Marchetti P
    J Heart Lung Transplant; 2004 May; 23(5 Suppl):S194-201. PubMed ID: 15093805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tacrolimus based immunosuppression.
    First MR
    J Nephrol; 2004; 17 Suppl 8():S25-31. PubMed ID: 15599882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Posttransplant diabetes. Metabolic consequences of posttransplant immunosuppressive treatment].
    Christiansen E
    Ugeskr Laeger; 2007 Jun; 169(24):2309-11. PubMed ID: 17594845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.